Cell-free DNA sequencing data of healthy control, atrophic gastritis, and gastric cancer patients’ blood
Sample cohort (n=48) is consisted of healthy, atrophic gastritis and gastric cancer patients. Some of the gastric cancer patients samples are collected at the separate time points: -1 before the operation; -2 after the operation; -3 during the control visit. For the hybridisation capture of the genes unique 15 gastric cancer-related gene panel was developed and very deep sequencing using TruSight Oncology Unique Molecular Identifier (UMI) Reagents (Illumina) was used.
- 48 samples
- DAC: EGAC00001003304
- Technology: Illumina NovaSeq 6000
Plasma Cell-free DNA Sequencing Study Data Access Policy
The scope of data access and publication is described in the approval of the Kaunas Regional Bioethics Committee (BE-2-31). Data is anonymised and encrypted and is available to registered users. There is a corresponding Data Access Committee (DAC) - Cell-free DNA Sequencing Data Access Committee - that determines access permissions. If you need to request access to this data set, please contact: Institute for digestive research (LSMU): Contact person: Greta Varkalaitė Email: greta.varkalaite@lsmuni.lt
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
| Study ID | Study Title | Study Type |
|---|---|---|
| Cancer Genomics |